Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

takeda pharma a/s - alógliptín - sykursýki, tegund 2 - drugs used in diabetes, dipeptidyl peptidase 4 (dpp-4) inhibitors - vipidia er ætlað í fullorðnir 18 ára og eldri með tegund 2 sykursýki til að bæta blóðsykursstjórnun ásamt öðrum glúkósa lækka lyf þar á meðal insúlín, þegar þessir, saman með fæði og æfingu, ekki veita fullnægjandi blóðsykursstjórnun (sjá kafla 4. 4, 4. 5 og 5. 1 fyrir tiltæk gögn um mismunandi samsetningar).

Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

advanced accelerator applications - lútetíum (177lu) oxódotreótíð - neuroendocrine tumors - aðrar lækninga geislavirk lyf - lutathera er ætlað fyrir meðferð unresectable eða sjúklingum, framsækin, vel þroskað (g1 og g2), somatostatini viðtaka jákvæð gastroenteropancreatic taugakirtilsuppruna æxli (gep‑netin) hjá fullorðnum.

Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

astrazeneca ab - járn sirkon cyclosilicate - blóðkalíumlækkun - Öll önnur lækningavörur - lokelma er ætlað fyrir meðferð hyperkalaemia í fullorðinn sjúklingar.

Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - brexpiprazole - geðklofa - psycholeptics - meðferð geðklofa.

Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - Æxlishemjandi lyf - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.

Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

biomarin international limited - valoctocogene roxaparvovec - antihemorrhagics - treatment of severe haemophilia a (congenital factor viii deficiency) in adult patients without a history of factor viii inhibitors and without detectable antibodies to adeno-associated virus serotype 5 (aav5).

Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - acitretinum inn - hart hylki - 25 mg

Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - acitretinum inn - hart hylki - 10 mg

Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - isotretinoinum inn - mjúkt hylki - 10 mg

Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - isotretinoinum inn - mjúkt hylki - 20 mg